Eshallgo executes 1-for-16 reverse stock split

Eshallgo Inc. (NASDAQ: EHGO) announced it will implement a 1-for-16 reverse stock split of its Class A and Class B ordinary shares, effective at market open on April 20, 2026.

The Shanghai-based office technology solutions provider said the consolidation aims to maintain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share for companies listed on The Nasdaq Capital Market.

Following the reverse split, every 16 existing shares will convert into one share. Class A ordinary shares will change from a par value of $0.0001 to $0.0016 per share, while Class B ordinary shares will undergo the same adjustment. The company's stock will continue trading under the symbol "EHGO" but will receive a new CUSIP number, G3121H111.

The consolidation will reduce outstanding Class A ordinary shares from approximately 26.51 million to approximately 1.66 million shares. Outstanding Class B ordinary shares will decrease from approximately 5.86 million to approximately 0.37 million shares. The company's authorized shares will be proportionally reduced.

Shareholders approved the reverse split at the company's annual general meeting on January 8, 2026, authorizing a consolidation ratio between 1-for-10 and 1-for-200. The board of directors approved the specific 1-for-16 ratio on April 10, 2026.

No fractional shares will be issued in connection with the reverse split. Shareholders will receive one full share in place of any fractional share that would result from the consolidation. The split will not alter shareholders' percentage ownership interests, and no action is required by shareholders holding shares through brokerage accounts.

Eshallgo provides integrated office and enterprise technology solutions, including artificial intelligence-enabled tools, to small and mid-sized businesses.

You May Also Be Interested In

• Exclusive: National Vision’s CEO on why the market got post-Q1 selloff wrong
• CervoMed raises $10 million in registered direct stock offering
• Autonomix Medical announces 1-for-21 reverse stock split